Clinuvel Pharmaceuticals Ltd has released a press release.
Appendix 4E and Preliminary Financial Report Reissued
Filed with ASX ·
Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Clinuvel Pharmaceuticals Limited on 6ix
Earlier from Clinuvel Pharmaceuticals
- CLINUVEL declares Full Year Dividend
- US FDA extends PDUFA date for SCENESSE
- US FDA sets PDUFA date for SCENESSE
- CUV103 Singaporean Phase II vitiligo study results
- Appeal Upheld Against NICE Recommendation in England
Later from Clinuvel Pharmaceuticals
- Dividend/Distribution - CUV
- FDA Clarifies SCENESSE PDUFA Date
- CLINUVEL renews CEO Employment Agreement
- FDA Grants Marketing Approval for SCENESSE
- TGA Priority Registration Pathway for SCENESSE
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals